Cargando…

In vitro and in vivo efficacy of the novel oral proteasome inhibitor NNU546 in multiple myeloma

Proteasome inhibition demonstrates highly effective impact on multiple myeloma (MM) treatment. Here, we aimed to examine anti-tumor efficiency and underlying mechanisms of a novel well tolerated orally applicable proteasome inhibitor NNU546 and its hydrolyzed pharmacologically active form NNU219. NN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Hui, Lei, Meng, Wang, Wang, Guo, Mengjie, Wang, Jia, Zhang, Haoyang, Qiao, Li, Feng, Huayun, Liu, Zhaogang, Chen, Lijuan, Hou, Jianhao, Wang, Xueyuan, Gu, Chenxi, Zhao, Bo, Izumchenko, Evgeny, Yang, Ye, Zhu, Yongqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746380/ https://www.ncbi.nlm.nih.gov/pubmed/33203800 http://dx.doi.org/10.18632/aging.104023

Ejemplares similares

Anti-tumor activity of a novel proteasome inhibitor D395 against multiple myeloma and its lower cardiotoxicity compared with carfilzomib
por: Shen, Xuxing, et al.
Publicado: (2021)

Lifelong nnU-Net: a framework for standardized medical continual learning
por: González, Camila, et al.
Publicado: (2023)

An Algorithm for Automatic Rib Fracture Recognition Combined with nnU-Net and DenseNet
por: Zhang, Junzhong, et al.
Publicado: (2022)

A Fusion Biopsy Framework for Prostate Cancer Based on Deformable Superellipses and nnU-Net
por: Altini, Nicola, et al.
Publicado: (2022)

The application of the nnU-Net-based automatic segmentation model in assisting carotid artery stenosis and carotid atherosclerotic plaque evaluation
por: Zhu, Ying, et al.
Publicado: (2022)

AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
por: Gu, Chunyan, et al.
Publicado: (2022)

Automatic epicardial adipose tissue segmentation in pulmonary computed tomography venography using nnU-Net
por: Hu, Yifan, et al.
Publicado: (2023)

Three-Dimensional Semantic Segmentation of Pituitary Adenomas Based on the Deep Learning Framework-nnU-Net: A Clinical Perspective
por: Shu, Xujun, et al.
Publicado: (2021)

Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
por: Gu, Chunyan, et al.
Publicado: (2023)

Inclusive jet production at $\sqrt{s} = 546 GeV$
por: Arnison, Geoffrey T J, et al.
Publicado: (1985)

Hepatic copper concentrations in 546 dogs (1982–2015)
por: Strickland, Jaimie M., et al.
Publicado: (2018)

546 Health Disparities Among Rural Burn Patients
por: Duggan, Robert P, et al.
Publicado: (2022)

Application of nnU-Net for Automatic Segmentation of Lung Lesions on CT Images and Its Implication for Radiomic Models
por: Ferrante, Matteo, et al.
Publicado: (2022)

An open-source nnU-net algorithm for automatic segmentation of MRI scans in the male pelvis for adaptive radiotherapy
por: Lorenzen, Ebbe Laugaard, et al.
Publicado: (2023)

Independent Validation of a Deep Learning nnU-Net Tool for Neuroblastoma Detection and Segmentation in MR Images
por: Veiga-Canuto, Diana, et al.
Publicado: (2023)

Mutations Y493G and K546D in human HSP90 disrupt binding of celastrol and reduce interaction with Cdc37
por: Peng, Bin, et al.
Publicado: (2016)

Preludes and fugues BWV 544, 541, 546, 542 and 536
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1992)

nnU-Net Deep Learning Method for Segmenting Parenchyma and Determining Liver Volume From Computed Tomography Images
por: Pettit, Rowland W., et al.
Publicado: (2022)

An Enhanced Variant Designed From DLP4 Cationic Peptide Against Staphylococcus aureus CVCC 546
por: Li, Bing, et al.
Publicado: (2020)

Targeting RFWD2 as an Effective Strategy to Inhibit Cellular Proliferation and Overcome Drug Resistance to Proteasome Inhibitor in Multiple Myeloma
por: Guo, Mengjie, et al.
Publicado: (2021)

Proteasome Inhibitors for the Treatment of Multiple Myeloma
por: Ito, Shigeki
Publicado: (2020)

Dimuon production in proton-antiproton collisions at $\sqrt{s}$ = 546 GeV
por: Bauer, G
Publicado: (1986)

546 Malignancies Associated to Primary Immunodeficiencies. A 40 Year Review
por: España, Corin, et al.
Publicado: (2012)

546. No Difference in MK-8591 and Doravirine Pharmacokinetics After Co-Administration
por: Matthews, Randolph, et al.
Publicado: (2018)

SUN-546 Coexistent Resistance to Thyroid Hormone Beta and Viral Thyroiditis
por: Golubic, Rajna, et al.
Publicado: (2019)

Synthesis of Giant Dendritic Polyphenylenes with 366 and 546 Carbon Atoms and Their High‐vacuum Electrospray Deposition
por: Hou, Ian Cheng‐Yi, et al.
Publicado: (2022)

Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
por: Gu, Yanyan, et al.
Publicado: (2020)

Rational Proteomic Analysis of a New Domesticated Klebsiella pneumoniae x546 Producing 1,3-Propanediol
por: Wang, Xin, et al.
Publicado: (2021)

New proteasome inhibitors in the treatment of multiple myeloma
por: Hungria, Vania Tietsche de Moraes, et al.
Publicado: (2019)

Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma
por: Zhang, Hua, et al.
Publicado: (2022)

Multiple diffraction theory of p$\overline{p}$ scattering at 546 GeV
por: Glauber, R J, et al.
Publicado: (1984)

Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1(N546K) Mutation
por: Capone, Stephen, et al.
Publicado: (2022)

SAT546 Papillary Thyroid Cancer Surveillance: Thyroglobulin Levels Affected by HAMA
por: Perez, Julienne Sanchez, et al.
Publicado: (2023)

Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits
por: Acosta-Alvear, Diego, et al.
Publicado: (2015)

Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma
por: Guo, Mengjie, et al.
Publicado: (2019)

Particle correlations in $\overline{p}$p collisions at 200, 546 and 900 GeV
por: Fuglesang, C
Publicado: (1988)

P546: MACHINE LEARNING AND RESPONSE TO INDUCTION CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Elhaddad, Heba, et al.
Publicado: (2023)

546. COVID-19 Monoclonal Antibody Use at a Stand Alone Children’s Hospital
por: Stimes, Grant T, et al.
Publicado: (2023)

Proteasome inhibition and its therapeutic potential in multiple myeloma
por: Chari, Ajai, et al.
Publicado: (2010)

Quantitative Phosphoproteomics of Proteasome Inhibition in Multiple Myeloma Cells
por: Ge, Feng, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_daneo9ak2io257k0p5i44e5hvc